Lynk Pharmaceuticals
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 8/29/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (9)
A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
Started: 8/29/2025
A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.
Started: 2/6/2024
A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA)
Started: 12/12/2023
A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis
Started: 3/18/2025
A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis
Started: 1/6/2022
A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis
Started: 1/26/2022
A Study of LNK01001 Capsule in Moderately to Severely Active Rheumatoid Arthritis
Started: 11/18/2021
Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.
Started: 7/12/2023
A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leukemia
Started: 4/8/2021